Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study

Journal of Critical Care

Volumn 26, Issue 2, 2011, Pages 201-205

  Piacentini, Enrique ^a   Sánchez, Baltasar ^a   Arauzo, Vanessa ^a   Calbo, Esther ^a   Cuchi, Eva ^a   Nava, Juan Manuel ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Community acquired bacterial pneumonia; Critically ill patients; H1N1 influenza A virus pneumonia; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HUMAN; INFLUENZA A (H1N1); INJURY SCALE; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; OBSERVATIONAL STUDY; OXYGEN TENSION; PARATHYROID HORMONE BLOOD LEVEL; PILOT STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; VIRUS PNEUMONIA;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; CRITICAL ILLNESS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PILOT PROJECTS; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; PROTEIN PRECURSORS;

EID: 79953784989     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.07.009     Document Type: Article

References (11)

1. Domidotlessnguez-Cherit G., Lapinsky S., Macias A., et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009, 302:1880-1887.
2. Jain S., Kamimoto L., Bramley A., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944. for the 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team.
3. Rello J., Rodriguez A., Ibanez P., et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009, 13:R148.
4. Itoh Y., Shinya K., Kiso M., et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
5. Toikka P., Irjala K., Juvén T., et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2009, 19:598-602.
6. Krüger S., Ewig S., Papassotiriou J., et al. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP-results from the German competence network CAPNETZ. Respir Res 2009, 10:65.
7. Hillas G., Vassilakopoulos T., Plantza P., et al. CRP and PCT as predictors of survival and septic shock in ventilator-associated pneumonia. Eur Respir J 2010, 35:725-727.
8. Okimoto N., Hayashi Y., Ishiga M., et al. Procalcitonin and severity of community-acquired pneumonia. J Infect Chemother 2009, 15:426-427.
9. Seligman R., Meisner M., Lisboa T., et al. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care10 2006, R125.
10. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44:S27-S72.
11. Libster R., Bugna J., Coviello S., et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010, 362(1):45-55.